SLC5A1 and diabetes mellitus: Additionally, emerging pharmacological interventions, such as GLP-1 receptor agonists, SGLT1/2 inhibitors, and DPP-4 inhibitors, offer promise not only for diabetes management but also for preventing cardiac remodeling and warrant further investigation for integration into perioperative care.